Higher levels are usually associated to higher tumor aggressiveness and worse prognosis, although in TNBC there is no established cut-off to define high vs. low Ki67 levels, differently from hormone receptor-positive BC35,43,44. This evidence concerns the gene MKI67 and neoplasm.